Trading Options with an Edge
Select Page

EDIT

Search by
TICKER SYMBOL

Editas Medicine Inc

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing

52.455

-5.385

(-9.31%)

Volume:

2,793,733

52 week range:

27.01 - 99.95

Market Cap:

3.581B

Company Description:

As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.